GLP-1 weight loss is different from calorie restriction dieting. Your hormones shift, your appetite changes, your muscle is at risk. A generic weight tracker misses all of this. tr8ck connects your weight trend to sleep, protein, exercise, and medication — so you understand what's driving results, not just what the scale says.
Calorie restriction alone produces a specific and well-understood weight loss pattern. GLP-1 therapy produces a more complex set of changes that generic weight apps are not designed to capture.
Semaglutide acts on GLP-1 receptors throughout the body — brain, gut, pancreas. The changes to appetite, satiety, and reward pathways are hormonal, not willpower-based. This means tracking mood and food noise alongside weight reveals the medication's brain-level effects — which a calorie app cannot do.
Research on GLP-1 medications shows that 25–40% of total weight loss can come from lean mass without deliberate protein tracking and resistance training. Generic weight apps show the scale going down — but can't distinguish fat loss from muscle loss. Tracking protein and exercise together with weight tells the real story.
Weight loss on Ozempic is not steady week-to-week. The injection cycle, dose escalation phases, water retention, and adaptation periods all create variability. A 4-week moving average is essential for reading the real trend — and understanding why progress looks uneven even when it's on track.
Poor sleep raises cortisol and ghrelin even in the presence of GLP-1 appetite suppression. Studies show that people losing weight in a sleep-deprived state lose a significantly higher proportion of muscle vs fat. Sleep is not a lifestyle bonus on GLP-1 therapy — it's a core weight loss variable.
Unlike traditional dieting where plateau causes are broad, GLP-1 plateaus typically stem from 3–4 specific, trackable causes: calorie creep, protein deficit, sleep deficit, or reduced activity. Having the data to diagnose which one — rather than guessing — is the whole point of GLP-1-specific tracking.
Most Ozempic and Wegovy users take these medications for years, not weeks. The data you accumulate over 12, 24, 36 months becomes a genuine picture of your health trajectory — and a powerful tool for prescriber conversations about dose management and long-term outcomes.
How you track your weight matters as much as tracking it at all. Most people tracking on GLP-1 therapy are doing it in a way that generates anxiety rather than insight.
MyFitnessPal and Lose It are excellent calorie trackers. They were built for calorie-counting dieters. GLP-1 users have fundamentally different tracking needs.
| Feature | MyFitnessPal | Lose It | tr8ck |
|---|---|---|---|
| Weight trend + 4-week average | Basic weight log | Basic weight log | ✓ Moving average + dose overlay |
| Protein tracking | ✓ Detailed macros | ✓ Detailed macros | ✓ Detailed macros + GLP-1 protein target |
| Sleep tracking | Not available | Not available | ✓ Full sleep quality module |
| Mood tracking | Not available | Not available | ✓ Daily mood + energy scoring |
| Injection / medication tracking | Not available | Not available | ✓ Full medication module with cycle mapping |
| AI cross-module weight correlation | Not available | Not available | ✓ Connects all modules automatically |
| GLP-1 dose history + weight overlay | Not available | Not available | ✓ Built specifically for this |
| Plateau diagnosis tools | Not available | Not available | ✓ AI surfaces most likely cause |
MyFitnessPal and Lose It are built for people counting calories. tr8ck is built for people on GLP-1 therapy. The questions you're asking are different — so the tool needs to be different.
Knowing what's typical at each phase prevents premature panic about stalls and helps you set realistic expectations for your personal journey.
Tolerability phase. Weight change is usually minimal — the starting dose is not therapeutic for weight loss. Focus on establishing your tracking routine, setting protein targets, and logging baseline sleep and mood. This data becomes your comparison point for everything that follows.
First real weight loss. Appetite suppression becomes meaningful at 0.5 mg and above. Expect 0.5–1.5 lbs/week on average, with variation. Nausea may peak here — track it carefully. This is when protein tracking becomes critical, as appetite suppression can drop intake too low.
Active weight loss phase. Nausea typically improves significantly. Appetite suppression is strong. Weight loss should be clearly visible in 4-week averages. Add or increase resistance training to protect muscle. First plateau risks appear as calorie intake normalises — watch your nutrition data.
Maintenance approach. Weight loss continues but typically slows as body weight decreases and metabolic rate adapts. The focus shifts to quality of loss (muscle preservation), sustainability of habits, and preparing for long-term maintenance. Your accumulated data history is now extremely valuable.
Every module in tr8ck has a direct connection to your weight loss outcomes on Ozempic. This is why GLP-1 users need a whole-health tracker, not just a scale app.
Average weight loss is 0.5–1.5 lbs per week across the active phase, though individual results vary significantly. Week-to-week variation is normal — some weeks show 2 lbs lost, others show 0 or a small gain due to water retention. The 4-week moving average is the meaningful metric, not any single week's number. Clinical trials for higher-dose semaglutide showed ~15% average body weight loss over 68 weeks.
Weigh once weekly under identical conditions: same day, same time (morning after waking), same scale on the same surface, same clothing or none. Calculate a 4-week moving average — this removes noise from water retention, hormonal cycles, and digestion. tr8ck does this automatically so you see the real trend, not daily fluctuation.
The most common correctable causes are: calorie creep as nausea eases, protein intake dropping (causing muscle loss and lowering metabolism), and sleep quality declining. As body weight decreases, metabolic rate also naturally adapts downward. tr8ck tracks all three controllable variables so you can identify which one is driving the slowdown rather than guessing.
Tracking protein is more important than tracking calories. The primary risk of GLP-1 appetite suppression is eating too little protein, which causes muscle loss, reduces metabolic rate, and slows long-term weight loss. Aim for 0.7–1g per pound of goal body weight daily. Total calorie awareness helps detect creep, but protein is the non-negotiable metric on semaglutide therapy.
The best semaglutide weight loss tracker connects your weight to injection history, sleep, protein, exercise, and mood — not just logs a number. tr8ck is built specifically for GLP-1 users: your weight trend is overlaid on your dose history, AI correlates all other modules automatically, and the 4-week average is always visible. It's the difference between a scale and an insight engine.
Free during early access. All 13 modules. AI-powered insights. No credit card required.
Try tr8ck FreeAlso worth reading